Cargando…

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

INTRODUCTION: No definitive data are available regarding the value of switching to an alternative TNF antagonist in rheumatoid arthritis patients who fail to respond to the first one. The aim of this study was to evaluate treatment response in a clinical setting based on HAQ improvement and EULAR re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro-Sarabia, Federico, Ruiz-Montesinos, Dolores, Hernandez, Blanca, Navarro-Compán, Victoria, Marsal, Sara, Barcelo, Mireia, Perez-Pampín, Eva, Gómez-Reino, Juan J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724400/ https://www.ncbi.nlm.nih.gov/pubmed/19627609 http://dx.doi.org/10.1186/1471-2474-10-91

Ejemplares similares

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
por: Hyrich, K. L., et al.
Publicado: (2008)

HAQ and DAS28 for clinical trials over months and MDHAQ, RheuMetric and psycho-socio-economic measures for long-term observations over years?
por: Pincus, Theodore
Publicado: (2022)

Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011)

Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2015)

The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort§
por: Boyd, Tristan A, et al.
Publicado: (2013)

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
por: Gomez-Reino, Juan J, et al.
Publicado: (2006)

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis
por: Hernández Alava, Mónica, et al.
Publicado: (2013)

Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
por: Min, Hong Ki, et al.
Publicado: (2022)

Work Disability in Scleroderma is Greater than in Rheumatoid Arthritis and is Predicted by High HAQ Scores
por: Ouimet, Janine M, et al.
Publicado: (2008)

Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation
por: Kumar, B. Siddhartha, et al.
Publicado: (2017)

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
por: Fleischmann, Roy M, et al.
Publicado: (2017)

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO
por: Llop, Maria, et al.
Publicado: (2022)

Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28
por: Carpenter, Lewis, et al.
Publicado: (2018)

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis
por: Hamann, Philip D H, et al.
Publicado: (2019)

DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
por: Greenmyer, Jacob R., et al.
Publicado: (2020)

Evaluation of the Psychometric Properties of the Health Assessment Questionnaire (HAQ) in a Population of Individuals With Multiple Sclerosis
por: Berardi, Anna, et al.
Publicado: (2022)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative
por: van Onna, Marloes, et al.
Publicado: (2021)

Pseudomonas aeruginosa DesB Promotes Staphylococcus aureus Growth Inhibition in Coculture by Controlling the Synthesis of HAQs
por: Kim, Sejeong, et al.
Publicado: (2015)

Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population
por: Patton, Thomas, et al.
Publicado: (2018)

EULAR Kongress-Splitter
por: Bach, Bianca
Publicado: (2021)

Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
por: Suarez-Gestal, Marian, et al.
Publicado: (2010)

Eular Textbook on Rheumatic Diseases
por: Adwan, Marwan H.
Publicado: (2015)

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
por: Carmona, Loreto, et al.
Publicado: (2006)

Use of Bayesian Multivariate Meta-Analysis to Estimate the HAQ for Mapping Onto the EQ-5D Questionnaire in Rheumatoid Arthritis
por: Bujkiewicz, Sylwia, et al.
Publicado: (2014)

The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans
por: Ruiz-Moreno, Juan S., et al.
Publicado: (2018)

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
por: Vander Cruyssen, Bert, et al.
Publicado: (2005)

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Eular 2020: Kurzer Überblick – Praxisrelevant …!
por: Lunzer, R., et al.
Publicado: (2020)

EULAR PARE: Knowledge Transfer Programme
por: Moskalewicz, Bożena, et al.
Publicado: (2020)

EULAR recommendations for intra-articular therapies
por: Uson, Jacqueline, et al.
Publicado: (2021)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
por: Maneiro, Jose Ramon, et al.
Publicado: (2015)

Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure – results of the Polish survey in the context of EULAR recommendations
por: Tłustochowicz, Małgorzata, et al.
Publicado: (2015)

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8dtu7njgfpuaoq99t19n49kgp